MedPath

A study to compare intravenous Iron with oral iron in treatment of cancer related anaemia.

Phase 3
Completed
Conditions
Health Condition 1: null- Patients with cancer who requires chemotherapy
Registration Number
CTRI/2016/01/006520
Lead Sponsor
Tata Memorial Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
192
Inclusion Criteria

1. Patient with cancer requiring chemotherpy

2. Hemoglobin less than or equal to 12

3. Hypochromic RBC >10%, Transferrin Saturation <20% or Serum Feritin <100 ug/L

4. Age > 18 yrs

5. Written Informed Consent

Exclusion Criteria

1. Known hypersensitivity to iron therapy

2. Uncontrolled medical illness

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath